Unitree's shares opened at RMB1,100 on August 19, 2026, nearly seven times the IPO price of RMB150.80 and giving the Hangzhou robotics manufacturer a market capitalization of approximately RMB444.9 billion. The first-day pop on Shanghai's STAR Market places Unitree's valuation above several established Chinese technology firms and signals sustained investor appetite for consumer robotics exposure despite broader market volatility in the sector.
The offering marks a sharp pivot for a company that spent its first eight years as a privately funded operation building quadruped robots in relative obscurity. Unitree shipped its first commercial quadruped, the A1, in 2020 at a price point roughly one-tenth that of Boston Dynamics' Spot. The company has since released multiple iterations of four-legged platforms and, more recently, entered the humanoid space with the G1 model announced in mid-2024. That product carried a launch price of $16,000 for the base configuration, undercutting comparable humanoid hardware from competitors including Agility Robotics and Figure by substantial margins. Unitree has not disclosed unit sales figures for the G1, but industry observers estimate several thousand units have shipped to research institutions and early commercial adopters since the product reached general availability in late 2025. The company's IPO prospectus, filed in June 2026, reported revenue of RMB3.2 billion for the fiscal year ending March 2026, though it did not break out margins by product line or geography.
The STAR Market listing follows a wave of robotics IPOs and direct listings across global exchanges over the past eighteen months. Agility Robotics filed for a U.S. listing in April 2026. Figure AI remains privately held but completed a $675 million Series B in March 2026 at a reported $3.2 billion valuation. ANYbotics, the Swiss quadruped specialist, listed on the SIX Swiss Exchange in January 2026. What distinguishes Unitree's debut is the valuation multiple. At RMB445 billion, the company is trading at roughly 139 times trailing twelve-month revenue, a premium that reflects both the scarcity of pure-play robotics equities available to mainland Chinese retail investors and expectations that Unitree's low-cost manufacturing model will translate to significant market share as humanoid robots move from pilots to production deployments. Analysts at CICC noted in a pre-listing research note that Unitree's Zhejiang manufacturing base gives it access to the same supply chain networks that scaled DJI's drone business, though the firm cautioned that humanoid gross margins remain unproven at volume.
Unitree's valuation now exceeds that of several publicly traded peers in the industrial automation and collaborative robotics segments, despite the company's narrow product range and limited enterprise customer base. The disparity underscores a broader tension in robotics equity markets: investors are paying substantial premiums for exposure to humanoid and legged platforms, even as the bulk of current robotics revenue still flows to traditional industrial arms, automated guided vehicles, and warehouse automation systems. Whether Unitree can defend its valuation will depend on its ability to sign large-scale deployment contracts with logistics, manufacturing, or service sector customers over the next twelve to eighteen months. The company's IPO documents indicated it plans to allocate approximately 40% of proceeds to expanding production capacity and 35% to research and development, with the remainder directed toward sales infrastructure and working capital. Unitree has not announced specific capacity expansion targets, but the capital raise positions the company to scale manufacturing ahead of anticipated demand from both domestic Chinese customers and international buyers navigating U.S.-China export restrictions on advanced robotics components.
What to Watch: Track whether Unitree announces a major enterprise deployment contract in logistics or manufacturing by the end of Q4 2026, which would validate the humanoid use case at scale. Monitor gross margin disclosures in the company's first quarterly earnings report as a public entity, expected in late November 2026, for early signals on whether the low-cost model holds as production ramps. Watch for potential secondary offerings or convertible debt issuances in early 2027 if the company accelerates its capacity expansion timeline ahead of expected 2027 volume production commitments.
